Orchid Pharma's newly-formed antimicrobial solutions division is targeting a turnover of up to Rs 300 crore in the next three ...

Focus has shifted from ‘ease’ to ‘speed’ of doing business in Andhra Pradesh, says IT Minister Lokesh. The government’s ...

HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

India faces a rising concern as diabetes increasingly links to neurodegenerative diseases like dementia and Alzheimer’s. With ...

Vadodara: One person was detained for questioning after the Central Bureau of Narcotics (CBN) conducted a raid on a ...

J&J faces lawsuits from more than 62,000 claimants who alleged that its baby powder and other talc products were contaminated ...

The oral drug, branded as Miplyffa, has now been approved for the treatment of Neimann-Pick disease type C - a rare genetic ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold ...

Indore: The food and drugs administration (FDA) department has identified over 40 pharmaceutical enterprises in Madhya Pradesh that has to undergo com.

Indian equity markets witnessed a remarkable surge, with both the Sensex and Nifty reaching new record highs. This upward momentum was largely attributed to a rally in global markets following the U.S ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...